The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000350.3(ABCA4):c.1531C>T (p.Arg511Cys)

CA958502

377402 (ClinVar)

Gene: ABCA4 (HGNC:24)
Condition: ABCA4-related retinopathy (MONDO:0800406)
Inheritance Mode: Autosomal recessive inheritance
UUID: 93e2382f-4088-4642-98a1-abb54b0fe297
Approved on: 2026-05-26
Published on: 2026-05-26

HGVS expressions

NM_000350.3:c.1531C>T
NM_000350.3(ABCA4):c.1531C>T (p.Arg511Cys)
NC_000001.11:g.94077713G>A
CM000663.2:g.94077713G>A
NC_000001.10:g.94543269G>A
CM000663.1:g.94543269G>A
NC_000001.9:g.94315857G>A
NG_009073.1:g.48437C>T
ENST00000370225.4:c.1531C>T
ENST00000649773.1:c.1531C>T
ENST00000370225.3:c.1531C>T
NM_000350.2:c.1531C>T
More

Pathogenic

Met criteria codes 5
PS4 PM3_Strong PP4 PP3 PM2_Supporting
Not Met criteria codes 1
BS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen ABCA4 Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for ABCA4 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
ABCA4 VCEP
The NM_000350.3(ABCA4):c.1531C>T variant in ABCA4 is a missense variant predicted to cause substitution of arginine by cysteine at amino acid 511; p.Arg511Cys. The total minor allele frequency in gnomAD v4.1.0 is 0.000078 (126/1613382 alleles), which is lower than the ClinGen ABCA4 VCEP’s threshold for PM2_Supporting (<0.0001). The computational predictor REVEL gives a score of 0.699 which is in the range of 0.644-0.772 meeting PP3. The prevalence of the variant in affected individuals is significantly increased compared with the prevalence in controls with an OR of 5.3 and CI of 2.44-10.82 (PS4; PMID: 35120629). At least one patient with this variant displayed presence of at least two ABCA4 variants identified by a gene panel of over 100 genes, onset under 18 years of age, macular flecks, which is highly specific for ABCA4-related retinopathy (PP4, PMID:33301772). This variant has been detected in at least four more individuals with ABCA4-related retinopathy. Of those individuals, all four were compound heterozygous for the variant and a pathogenic or likely pathogenic variant not confirmed in trans (p.Arg602Trp; p.Thr1537Met; p.Gly1961Glu; p.Arg2107His) (PM3_Strong; PMID:32307445, 26780318, 29925512, 33261146). In summary, this variant meets the criteria to be classified as pathogenic for ABCA4-related retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen ABCA4 VCEP (Specification Version 1.0.0): PS4, PM3_Strong, PP4, PP3, PM2_Supporting.
Met criteria codes
PS4
The prevalence of the variant in affected individuals is significantly increased compared with the prevalence in controls. The OR is 5.3 and the CI is 2.44-10.82, which is above the ABCA4 VCEP threshold of ≥5, where the CI does not contain 1 (PS4; PMID: 35120629).
PM3_Strong
This variant has been detected in at least four more individuals with ABCA4-related retinopathy. Of those individuals, all four were compound heterozygous for the variant and a pathogenic or likely pathogenic variant not confirmed in trans (p.Arg602Trp; p.Thr1537Met; p.Gly1961Glu; p.Arg2107His)(2.25 PM3 points; PM3_Strong; PMID:32307445, 26780318, 29925512, 33261146).
PP4
At least one patient with this variant displayed presence of at least two ABCA4 variants identified by a gene panel of over 100 genes, onset under 18 years of age, macular flecks, which is highly specific for ABCA4-related retinopathy (PP4, PMID:33301772).
PP3
The computational predictor REVEL gives a score of 0.699 which is in the range of 0.644-0.772, evidence that predicts a damaging effect on ABCA4 function (PP3).
PM2_Supporting
The total minor allele frequency in gnomAD v4.1.0 is 0.000078 (126/1613382 alleles), which is lower than the ClinGen ABCA4 VCEP’s threshold for PM2_Supporting (<0.0001).
Not Met criteria codes
BS1
GrpMax = 0.0010066 < 0.00163
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.